HLB Life Science Co. Ltd (067630) — Cash Flow Quality Index
HLB Life Science Co. Ltd (067630) has a Cash Flow Quality Index of -5.16x as of December 2024. Operating cash flow of ₩-32.01 Billion is below net income of ₩6.21 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore HLB Life Science Co. Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HLB Life Science Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for HLB Life Science Co. Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does HLB Life Science Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for HLB Life Science Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for HLB Life Science Co. Ltd. For live market cap and the full company financial profile, see 067630 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -5.16x | ₩-32.01 Billion | ₩6.21 Billion | ▼ -13149.7% |
| 2017 | -0.04x | ₩-302.04 Million | ₩7.76 Billion | ▼ -100.5% |
| 2014 | 7.43x | ₩10.43 Billion | ₩1.40 Billion | — |